The active implantable medical devices are partially or totally introduced into the body by the surgical procedure in a natural orifice. These devices remain in that position after the procedure & rely on external electrical energy source to function. These devices play an important role in management of a number of diseases for instance cardiovascular devices, epilepsy, spasticity, Parkinson’s disease, and patients with hearing or visual impairment. The key benefits are included implant stability, high strength, Resistance to hydrolysis & effects of ionizing radiation and Radiolucent without imaging artifacts in X-rays, CT and MRI scans.
According to study, “Global Active Implantable Medical Devices Market: Market Segments: By Product Type (Implantable Cardioverter Defibrillators, Neurostimulators, Implantable Cardiac Pacemakers, Implantable Hearing Devices, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders); and Region – Analysis of Market Size, Share & Trends for 2014 – 2019 and Forecasts to 2030” the key companies operating in the global active implantable medical devices market are Zimmer Biomet, Smith & Nephew, Boston Scientific Corporation, Cochlear Ltd., Johnson & Johnson Services, Inc., Abbott, Straumann AG, Medtronic, Biotronik SE & Co. KG, LivaNova PLC, Stryker, Integra Lifesciences Holdings Corporation, William Demant Holding A/S, Sonova Holding AG, Nurotron Biotechnology Co. Ltd., C.R. Bard Inc., Allergan Inc., NuVasive, Inc., 3M, Dentsply Sirona, Cardinal Health, Inc., Microport Scientific Corporation, Globus Medical, Inc., CONMED Corporation, and MED-EL.
The market is driven by rise in prevalence of neurological disorders, followed by expanded applications of neurostimulators, increase in burden of cardiovascular diseases, rise in investments & funds to develop technologically advanced products and favorable reimbursement scenario for ENT procedures in developed countries. However, high cost of implants and an unfavorable reimbursement scenario, issues related to the use of implantable medical devices and unfavorable healthcare reforms may impact the market. Moreover, growth in development of Subcutaneous Implantable Cardioverter Defibrillators (S-ICDs) is a key opportunity for market.
Based on product, market is segmented as implantable cardiac pacemakers, implantable cardioverter defibrillators, implantable heart monitors or inserted loop recorders, ventricular assist devices, implantable hearing devices and neurostimulators. Implantable cardioverter defibrillators are further sub-segmented as Subcutaneous Implantable Cardioverter Defibrillators and Transvenous Implantable Cardioverter Defibrillators (Single-Chamber Implantable Cardioverter Defibrillators, Dual-Chamber Implantable Cardioverter Defibrillators and Biventricular Implantable Cardioverter Defibrillators (ICDs)/Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)). Implantable hearing devices segment is further sub-segmented as active hearing implants and passive hearing implants. Additionally, neurostimulators is also further sub-segmented as deep brain stimulators, vagus nerve stimulators, spinal cord stimulators, sacral nerve stimulators and gastric electrical stimulators. Based on application, market is segmented as neurological, cardiovascular, hearing impairments and others. In addition, based on end-user, market is segmented as cardiac centers, ambulatory centers, dental clinics, hospitals and others.
Based on geography, the North-American region holds major share in global market owing to increase in development of innovative & technology advanced products, high accessibility to advanced technologies and rise in healthcare expenditure in the region. Whereas, the Asian-Pacific and European regions are estimated to exhibit substantial growth rate due to rise in incidence of chronic diseases, less stringent regulations and increase in healthcare reforms for infrastructural development during the forecast period.
For More Information, click on the link below:-
Global Active Implantable Medical Devices Market Research Report
Related Report:-
Contact Us:-
Ken Research
Ankur Gupta, Head Marketing & Communications
+91-9015378249